Stock Price Quote

VENMAX DRUGS AND PHARMACEUTICALS LTD.

NSE : NABSE : 531015ISIN CODE : INE154G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE27.951 (+3.71 %)
PREV CLOSE ( ) 26.95
OPEN PRICE ( ) 27.21
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4221
TODAY'S LOW / HIGH ( )26.00 28.19
52 WK LOW / HIGH ( ) 6.2730.88
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
- Chairman - Managing Director
Registered Office

Address Shed No 22, Plot No 84,Phase-1,I D A Cherlapally,
Hyderabad,
Telangana-500051

Phone 09550101503

Email venmaxdrugs@gmail.com

Website www.venmaxdrugs.com

Registrars Details
Cil Securities Ltd
214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,,Hyderabad
Listing : BSE

NEWS

05May Venmax Drugs and Pharmaceuticals infor
Pursuant to SEBI Circular dated August 10, 2021, with regard to fund rai..
10Feb Venmax Drugs & Pharmaceuticals informs
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
17Sep Venmax Drugs And Pharmaceuticals infor
Venmax Drugs And Pharmaceuticals has informed that it attached Financial..
10Sep Venmax Drugs and Pharmaceuticals infor
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
13Nov Venmax Drugs And Pharmaceuticals infor
Venmax Drugs And Pharmaceuticals has informed that it has not received a..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit7.78-0.1
Gross Profit 7.75 -0.14
Operating Profit 7.77-0.0700000000000003
Net Sales 3.338.07

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  30560.85 (0.62%)
M.Cap ( in Cr)64939.67
Divi's Lab (BSE)
peergroup  6281.35 (1.16%)
M.Cap ( in Cr)166750.11
Medplus Health Servi (BSE)
peergroup  887.25 (8.45%)
M.Cap ( in Cr)10619.84
Wockhardt (BSE)
peergroup  1329.20 (3.49%)
M.Cap ( in Cr)21597.58
Jubilant Pharmova (BSE)
peergroup  945.50 (4.37%)
M.Cap ( in Cr)15060.03

Shareholding Pattern

NON-INSTITUTION 76.72%
PROMOTERS 23.13%
FI/BANKS/INSURANCE 0.15%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Venmax Drugs And Pharmaceuticals Ltd.

Venmax Drugs And Pharmaceuticals Ltd. was incorporated in the year 1988. Its today's share price is 27.95. Its current market capitalisation stands at Rs 14.64 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.1.99 Cr. The company's management includes Priyanka Agarwal, Swapneshwar Mishra, Gundluru Reddappa, P Meena Kumari, Dasi Reddy Rakesh.

It is listed on the BSE with a BSE Code of 531015 , NSE with an NSE Symbol of and ISIN of INE154G01022. It's Registered office is at Shed No 22, Plot No 84,Phase-1,I D A CherlapallyHyderabad-500051, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Durga Prasad Associates, GLN Prasad & Co LLP, Madhu & Associates, NSVR & Associates LLP, PPKG & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.